Product Name
Human PDCD1 / PD-1 / CD279 Jurkat Cell Line
Expression System
Mammalian Expression System
Concentration
Approximately 5 × 106 cells/vial
Application
This overexpression cell line is suitable for a wide range of applications, including but not limited to functional studies of the target gene/protein, receptor signaling and pathway analysis, ligand screening, and cellular localization studies. The fluorescent reporter enables real-time monitoring of expression and facilitates cell sorting and imaging-based assays. The cell line can also be used in drug discovery, target validation, and mechanism-of-action (MoA) studies.
Growth Conditions
1640 + 10% FBS + 2 μg/mL Puromycin
Growth Properties
Suspended
Mycoplasma Status
Negative
Storage
90 % FBS + 10 % DMSO
Vapor phase of liquid nitrogen
Shipping Conditions
Dry Ice
Target
PDCD1 / PD-1 / CD279
Description
The human PDCD1 / PD-1 / CD279 Jurkat cell line, at a concentration of 1 × 105 cells per well, can bind to nivolumab with the EC50 of 0.403 nM.
Industry Terms
Not Available to Industry
